IDXX financials
Idexx Laboratories (IDXX) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
IDXX income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $4.30B | $2.66B | $1.36B | $1.06B | 13.08 |
| 2024 | $3.90B | $2.38B | $1.13B | $887.87M | 10.67 |
| 2023 | $3.66B | $2.19B | $1.10B | $845.04M | 10.06 |
| 2022 | $3.37B | $2.00B | $898.76M | $679.09M | 8.03 |
| 2021 | $3.22B | $1.89B | $932.03M | $744.85M | 8.60 |
| 2020 | $2.71B | $1.57B | $694.52M | $581.78M | 6.71 |
- IDXX revenue was $4.30B in fiscal 2025, net income $1.06B.
Updated 2026-11-02 17:55 UTC